KLYV THERAPEUTICS AS
Operating
Utvikle og investere i legemidler, legemiddelkandidater, hjelpemidler,
verktøy og metoder for pasientbehandling og persontilpasset medisin.
Utvikling av legemidler.
Organization
- CEO
- MV
Maria Vistnes1983
- Chairman of the board
- AB
Andreas Berg1965
- Years since formation
- 3 years
- since Oct 24, 2023
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 102,540
- 1 share class
- Total number of shareholders
- 4
- 3 companies, 1 person
- Belongs to group of
Financials
- Total operating income 2025
- 2,206,613
- NOK
- Annual total result 2025
- -1,061,433
- NOK
- Total equity 2025
- 6,662,092
- NOK
Last update: Jun 17, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MV 1983 | Managing Director/CEO | 39.32 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
AB 1965 | Chairman | 20.12 % indirectly |
MV 1983 | Board Member | 39.32 % indirectly |
BL | Board Member | - |
TS 1972 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JR 1982 | - | 39.32 % indirectly |
MV 1983 | Managing Director/CEO, Board Member | 39.32 % indirectly |
AB 1965 | Chairman | 20.12 % indirectly |
Last update: Dec 3, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 80,635 | 78.64 % | |
| Ordinary shares | 20,635 | 20.12 % | |
| Ordinary shares | 635 | 0.62 % | |
BL | Ordinary shares | 635 | 0.62 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK 0Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 2,206,613 | 745,900 | 0 |
Annual Total Result | -1,061,433 | 148 | -2 |
Total assets | 7,815,848 | 934,460 | 94,429 |
Total liabilities | 1,153,756 | 334,314 | 0 |
Total equity | 6,662,092 | 600,146 | 94,429 |
P&L
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 2,206,613 | 745,900 | 0 |
Total operating costs | 3,271,657 | 750,792 | 2 |
Operating result | -1,065,045 | -4,892 | -2 |
Financial income/costs | 3,612 | 5,039 | 0 |
Profit before tax | -1,061,433 | 148 | -2 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -1,061,433 | 148 | -2 |
Balance overview
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total fixed assets | 0 | 0 | 0 |
Total current assets | 7,815,848 | 934,460 | 94,429 |
Total assets | 7,815,848 | 934,460 | 94,429 |
Short term debt | 1,153,756 | 334,314 | 0 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 1,153,756 | 334,314 | 0 |
Contributed capital | 7,600,424 | 600,000 | 94,430 |
Retained earnings | -938,332 | 146 | -2 |
Total equity | 6,662,092 | 600,146 | 94,429 |
Total equity and liabilities | 7,815,848 | 934,460 | 94,429 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises